Likewise, while VGlut1 is decreased in AD patients, particularly in the later stages (Kashani et al., 2008), patients with early stages of mild cognitive impairment (MCI) demonstrate increased VGLUT (Bell et al., 2007). This evidence concerns the gene SLC17A7 and Cognitive impairment.